ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Radius Announces Update on Tymlos (abaloparatide) Label Drugs
December 29, 2021Radius Health, Inc. (“Radius” or the “Company”) (NASDAQ: RDUS) today announced that the U.S. Food and Drug Administration (FDA) has approved updates to the Tymlos label, including the removal of the boxed warning regarding the risk of osteosarcoma.
Pharma Sources Insight July 2025
